Resultados de la búsqueda 81-90 of 6297 for Selective mutism

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or "SERM", which help block estrogen from attaching to cancer cells.

2. Mayo Clinic Ophthalmology Physician Update - August 2023

   Page 1.

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or "SERM", which help block estrogen from attaching to cancer cells.

4. Hematología - Ensayos clínicos - Mayo Clinic

   The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival (OS) ...

5. NF2-related schwannomatosis (neurofibromatosis type 2) - Síntomas y causas - Mayo Clinic

   It causes tumors to grow on the hearing and balance nerves, most often in both ears, which can lead to hearing loss. The gene change that causes the tumors can ...

6. Mayo Clinic Otolaryngology Physician Update - September 2025

   Page 1.

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or "SERM", which help block estrogen from attaching to cancer cells.

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

9. Mayo Clinic Pulmonology Physician Update - December 2024

   Page 1.

10. Hematología - Ensayos clínicos - Mayo Clinic

    The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival (OS) ...